id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1445167,3b3d64e7-7e64-40cc-afcd-e78794345f22,Q3,KNIGHT CAPITOL CONSULTANTS,40036301,GENZYME CORPORATION,2013,third_quarter,PHA,"Adequate funding for programs of the Food and Drug Administration, including implementation of the Prescription Drug User Fee Act (FY 2014 appropriations for the FDA, H.R. 2410/S. 1244/H.J. Res. 59).  Assess potential impact of sequestration on public health/food and drug programs (FY 2014 appropriations for HHS, S. 1284).","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2013-10-16T19:33:34.300000-04:00